SCHEMBL7349136

SCHEMBL7349136

O=C(COCc1ccccc1)N[C@@H](Cc1ccccc1)C(=O)CSCc1ccco1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.45
POLB P06746 4/20 0.45
HPGD P15428 3/20 0.43
MAPT P10636 3/20 0.43
USP2 O75604 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
HSD17B10 Q99714 2/20 0.40
ACE P12821 1/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
GPR34 Q9UPC5 3/20 0.39
MBTPS1 Q14703 1/20 0.39
KMT2A Q03164 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303430 0.91 PSMB5 (0.45) PTPN1
SCHEMBL7350634 0.88 ALDH1A1 (0.58) ALDH1A1POLBHPGDMAPTUSP2
SCHEMBL7347081 0.85 TACR1 (0.49) ALDH1A1
SCHEMBL7347088 0.85 TACR1 (0.49) ALDH1A1
SCHEMBL7304120 0.84 APC (0.48) ALDH1A1POLBHPGDMAPTUSP2
SCHEMBL7304130 0.84 APC (0.48) ALDH1A1POLBHPGDMAPTUSP2
SCHEMBL7346557 0.84 CTSG (0.48) ALDH1A1POLBHPGDMAPTSMN1; SMN2
SCHEMBL7346551 0.84 CTSG (0.48) ALDH1A1POLBHPGDMAPTSMN1; SMN2
SCHEMBL7347741 0.84 GPR34 (0.54) ALDH1A1POLBHPGDMAPTUSP2
SCHEMBL7341642 0.84 HPGD (0.53) ALDH1A1POLBHPGDMAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0603873-B1 Aminoketone derivatives MITSUBISHI CHEM CORP (JP) 1998-04-15 EP disclosed
US-5424325-A Inibitors of thiol protease and may be used as therapeutic agents for treating muscular dystrophy, cataracts, strokes MITSUBISHI KASEI CORPORATION (JP) 1995-06-13 US disclosed
EP-0603873-A1 Aminoketone derivatives Mitsubishi Chemical Corporation (JP) 1994-06-29 EP disclosed